Considerable Variation Seen in Commercial Pricing for Surgery Services
By Elana Gotkine HealthDay Reporter
THURSDAY, July 3, 2025 -- Commercial pricing varies considerably for general surgery services, with facility prices exhibiting greater variability, according to a research letter published online June 25 in JAMA Network Open.
Alexander P. Philips, and Christopher M. Whaley, Ph.D., both from Brown University School of Public Health in Providence, Rhode Island, examined price data from ClarifyHealth for common surgical services across four large national insurers, which constitute 78 percent of market share. Commercial prices were analyzed for practitioners and facilities with billed claims during 2023 for 10 common general surgery procedures.
The sample included approximately 2.45 million price points and 97,740 unique physicians for professional data, as well as 132,000 price points and 5,298 unique facilities for facility data. The researchers found that the magnitude of facility prices was about nine and four times higher than professional prices for surgical and endoscopic procedures, respectively. Price variation was moderate and high for professional services and facility services, respectively, especially for endoscopic procedures. For example, the median facility cost for diagnostic colonoscopy ranged from $925 to $3,571 depending on the payer. For diagnostic colonoscopy, professional and facility prices have an upper limit of about two and about three times the lower bound, respectively.
"If price variation reflects clinical or perceived quality variation, purchasers and policymakers must find the balance between receiving higher-quality care and spending financial resources elsewhere," the authors write. "If price variation is instead driven by consolidation or anticompetitive contracting, then regulators should design policies that ensure competitive health care markets."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.